Boston Biomedical, Inc. Announces Investment by its Parent Company in MPM Oncology Innovations Fund

 

Boston Biomedical, Inc. Announces Investment by its Parent Company in MPM Oncology Innovations Fund

The INV and IRF are a unique, first-of-its-kind, impact investing collaboration, which partners fundraising for biotech venture capital investing with philanthropic fundraising for cancer research.

More Boston Biomedical, Inc. Announces Investment by its Parent Company in MPM Oncology Innovations Fund Videos

Leave a Reply